Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
about
The genetics and neuropathology of frontotemporal lobar degenerationMolecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersPhenotypic Heterogeneity of Monogenic Frontotemporal DementiaMechanisms of granulin deficiency: lessons from cellular and animal modelsBiomarkers in dementia: clinical utility and new directionsPotential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairmentA neurodegenerative disease mutation that accelerates the clearance of apoptotic cellsProgranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation.Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation.Evidence of the innate antiviral and neuroprotective properties of progranulin.Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathyRecent insights into the molecular genetics of dementiaSuberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.Progranulin protein levels are differently regulated in plasma and CSF.Genetics of dementia.Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin.Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma.Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese populationrs5848 polymorphism and serum progranulin levelAssociation of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.Brain progranulin expression in GRN-associated frontotemporal lobar degenerationDetermining the binding affinity of therapeutic monoclonal antibodies towards their native unpurified antigens in human serum.Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodiesLow plasma progranulin levels in children with autism.TMEM106B a novel risk factor for frontotemporal lobar degenerationProgranulin: a growth factor, a novel TNFR ligand and a drug targetPlasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.Insights into the role of progranulin in immunity, infection, and inflammation.Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic featuresAdvances in understanding the molecular basis of frontotemporal dementia.Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.Progranulin contributes to endogenous mechanisms of pain defense after nerve injury in mice.Promoter DNA methylation regulates progranulin expression and is altered in FTLD.Therapy and clinical trials in frontotemporal dementia: past, present, and future.Primary progressive aphasia: clinicopathological correlations.
P2860
Q24615201-711CF8B3-3617-4555-9170-FF21BC35C0A4Q26766487-940D3C71-01FB-4E7E-BCC1-B1071B11089EQ26782984-293213B0-60C7-4267-90A8-1C7E1EA1FA95Q26824221-6AF70E84-3A9D-43CF-BBFB-9D7E439403E1Q27007086-4A6473CF-B059-4AB0-AFFA-2FF633F85EEEQ27011876-2AE1A223-6C78-4FCF-8F80-3374E8EF59FBQ30498840-BCD36987-A077-4AD8-823E-C76026B1FE95Q30754508-21F7D8AB-6AAD-4D9C-97DF-E377915B9540Q33685394-48F1A485-4C23-462F-99F3-1E531EEFDA3CQ33690042-67BADC02-C1A8-4FD3-99F4-4624DF90A47DQ33725391-FA6CAF05-816B-4210-AB18-01774A7AB705Q33830518-0E372200-3E80-4D9D-9C05-6895173C9947Q33859252-1E6699A2-2C97-4B5D-AA46-09C575A2837DQ33927199-A83D974B-F042-43CD-A20C-F5015803112CQ34248849-B91A0E43-AA05-4DCB-BA06-EF6A862E2859Q34346014-2224A98D-3EAE-489F-B26F-E60895347022Q34381669-168FAE88-6E8A-4BA6-B2B8-3E139388F647Q34559477-D2D17AB6-D4FF-428F-9784-584E04B15E69Q34891810-05C15ABF-A602-4A4F-895B-4729A02CB8F4Q34959322-6575B7AF-9C9B-448B-912D-20CF840E3016Q35014879-B714982C-3143-4F11-A573-A50AA0C704A9Q35040430-94A07063-822D-42DA-9971-B8B071A68109Q35204586-F2119A6C-8A82-49B2-BC0F-146261BC0BACQ35234677-B8DB541B-D3B6-4277-A810-1E55FB939161Q35240854-1B34726A-BB69-4E00-B6E9-1AF0F637C5C0Q35512313-268D004E-D99A-4BEB-8866-E5CE4C38297FQ35601050-25CD4BFA-F34F-4555-8AC2-08FB62303D2AQ35859333-6EC9E2B6-8CA8-4F7B-BB0D-5482500C83F6Q36003800-50609FA2-7AD1-407F-AE7A-F3074FC8ECBBQ36061223-B6253B97-D7D8-4EC7-A256-A5DF5B29E16EQ36294670-D1845B09-C5FB-4572-986B-4F20A52BBE31Q36534831-E195D275-D975-4714-80C2-56ECD5F696C8Q36535668-746AAA50-A220-42BB-B0C7-DF4B60C47A93Q36775677-006650DE-595F-4036-AA99-C55C42BBE16BQ37235164-9DAF8108-30C8-44EA-87AE-1DDDCE3EC5A4Q37293615-4AEF104C-1AC5-4266-9115-5DC92366D91BQ37294604-1EF8F674-602F-4E5E-A6D6-E1856F5AC3A1Q37485657-C984A11D-3AB7-4299-90C5-82E711875D14Q37566888-AF61ED32-B4BE-4E19-88C1-2D10A8DCC0F8Q37688883-F45AB90B-B2FB-4470-AAB6-5BB91B9AB721
P2860
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@en
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@nl
type
label
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@en
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@nl
prefLabel
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@en
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@nl
P2093
P50
P356
P1433
P1476
Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
@en
P2093
Ilse Gijselinck
Karin Peeters
Kristel Sleegers
Marc Cruts
Maria Mattheijssens
Peter P De Deyn
P304
P356
10.1002/ANA.21621
P50
P577
2009-05-01T00:00:00Z